SEC Form 4 · accession 0001179110-17-008472
ABBOTT LABORATORIES · ABT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Andrew H Lane
Officer — Executive Vice President
Period of report
Jun 1, 2017
Accepted (ET)
Jun 2, 2017 · 6:31 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000001800
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common shares without par valueF1 | Jun 1, 2017 | A | 3,007 | $0.00 | A | 23,495 | D | |
| Common shares without par value | Jun 1, 2017 | F | 602 | $45.66 | D | 22,893 | D | |
| Common shares without par valueF2 | holding | — | — | — | 841 | I | Profit Sharing Trust |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Settlement of a performance-based restricted stock unit in shares in a transaction exempt from Section 16(b) under Rule 16b-3.
- F2Balance in the Abbott Laboratories Stock Retirement Trust as of June 1, 2017.